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Abstract
Background: Typhoid fever, caused by Salmonella Typhi, follows a fecal-oral transmission route and is a major
global public health concern, especially in developing countries like Bangladesh. Increasing emergence of
antimicrobial resistance (AMR) is a serious issue; the list of treatments for typhoid fever is ever-decreasing. In
addition to IncHI1-type plasmids, Salmonella genomic island (SGI) 11 has been reported to carry AMR genes.
Although reports suggest a recent reduction in multidrug resistance (MDR) in the Indian subcontinent, the
corresponding genomic changes in the background are unknown.
Results: Here, we assembled and annotated complete closed chromosomes and plasmids for 73 S. Typhi
isolates using short-length Illumina reads. S. Typhi had an open pan-genome, and the core genome was
smaller than previously reported. Considering AMR genes, we identified five variants of SGI11, including the
previously reported reference sequence. Five plasmids were identified, including the new plasmids pK91 and
pK43; pK43and pHCM2 were not related to AMR. The pHCM1, pPRJEB21992 and pK91 plasmids carried AMR
genes and, along with the SGI11 variants, were responsible for resistance phenotypes. pK91 also contained
qnr genes, conferred high ciprofloxacin resistance and was related to the H58-sublineage Bdq, which shows
the same phenotype. The presence of plasmids (pHCM1 and pK91) and SGI11 were linked to two H58-
lineages, Ia and Bd. Loss of plasmids and integration of resistance genes in genomic islands could contribute
to the fitness advantage of lineage Ia isolates.
Conclusions: Such events may explain why lineage Ia is globally widespread, while the Bd lineage is locally
restricted. Further studies are required to understand how these S. Typhi AMR elements spread and generate
new variants. Preventive measures such as vaccination programs should also be considered in endemic countries; such
initiatives could potentially reduce the spread of AMR.
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Background
Typhoid fever, a major global public health threat, is
caused by Salmonella enterica serovar Typhi (S. Typhi).
Due to its fecal-oral transmission route, the disease is
most prevalent in the least developed regions of the
world in the tropical belt, which also contains the least
developed regions of the world. Over 80% of the global
burden of 12 million typhoid cases per year occurs in
Asia and Africa, mainly among children and adolescents
[1–3]. Although the mortality rate is low (1–2%), ty-
phoid fever may lead to long-term physical and mental
disabilities if untreated for a long time [4]. Moreover, the
huge numbers of typhoid fever cases in developing
countries impose a significant economic burden.
Antimicrobial therapy is the most effective treatment
for typhoid fever. However, due to increasing levels of
antimicrobial resistance (AMR), a small number of cases
of treatment failure have been reported, even among pa-
tients treated with newer generations of antimicrobials
[5–7]. Multidrug resistance (MDR) in S. Typhi—defined
as co-occurring resistance to ampicillin (amp), chloram-
phenicol (chl) and cotrimoxazole (sxt)—was first re-
ported in 1973 [8, 9] and resistance to ciprofloxacin
(cip) emerged in the early 1990s. The list of available
treatment options for typhoid fever has rapidly reduced
since the emergence of AMR and treatment regimens
have shifted towards quinolones. Extended-spectrum
beta-lactams (e.g. ceftriaxone) or macrolides (e.g. azi-
thromycin) are now the most effective treatment options
for typhoid fever. However, extended-spectrum beta-
lactamase (ESBL)-producing S. Typhi have been re-
ported in many countries, and exhibit high levels of re-
sistance to ceftriaxone (cro) [10–12].
In S. Typhi, MDR genes are usually carried by an
IncHI1-type plasmid [13, 14]. However, a chromosomal
Tn21-like element has recently been reported as a com-
ponent of Salmonella genomic island 11 (SGI11) [15,
16]. This island has been reported to carry resistance
genes for seven different antimicrobial agents, including
ampicillin, chloramphenicol, and cotrimoxazole, it inte-
grates into two or more chromosomal locations, and can
confer MDR even in the absence of plasmids [16–18].
MDR has also been closely associated with the dominant
haplotype H58 (genotype 4.3.1), which exhibits reduced
susceptibility to quinolones [16]. Mechanisms of cipro-
floxacin resistance (cip-R) usually involve chromosomal
point mutations and the acquisition of AMR genes. Such
mutations occur in quinolone resistance-determining re-
gions (QRDR), which correspond to multiple locations
on the DNA gyrase (gyrA and gyrB) and topoisomerase
IV (parC and parE) genes [19–22]. The presence of
plasmid-mediated quinolone resistance (PMQR) genes,
such as qnr, and overexpression of efflux pump genes
can also contribute to quinolone resistance [23, 24].
Although H58 is still the most prevalent MDR S.
Typhi variant, a reduction in the frequency of isolation
of H58-MDR strains has been reported. These isolates
are only resistant to one or two antibiotics, i.e., ampicil-
lin, chloramphenicol, or cotrimoxazole [25–29]. None-
theless, the genomic changes to chromosomes or
plasmids responsible for such H58 non-MDR pheno-
types are yet to be described.
In this study, we generated the complete closed
chromosome sequences and accessory plasmid se-
quences for 73 S. Typhi strains isolated in Bangladesh
between 1999 and 2013; the strains were selected for this
study according to their antimicrobial resistance profile.
We annotated and studied the core and pan-genomes of
all isolates (n = 73). The genetic elements responsible for
AMR (e.g. genes, mutations, genomic islands) and their
locations (plasmids or chromosome) were analyzed and
compared with the resistance phenotypes. We also
assessed the presence, location and gene contents of
SGI11 and plasmids and their associations with resist-
ance phenotypes.
Results
General genomic features and comparative genomics
The chromosomes of all 73 S. Typhi isolates were assem-
bled and ranged from 4,773,823 to 4,897,593 base pairs
(bp) in size (Additional file 1: Table S2). The GC content
of all chromosomes was 53%. Automatic gene annota-
tion showed an average of 4236 (median 4230) chromo-
somal genes, with an average size of 643 bp per coding
sequence (Additional file 1: Table S2). The numbers of
genes encoding hypothetical proteins, tRNAs, rRNAs,
and pseudogenes in all isolates ranged from 871 to 949,
75–84, 21–24, and 171–195, respectively (Additional file
1: Table S2). The lowest and highest ANIb/ANIm values
were 99.89–100/99.85–99.92 respectively (Additional file
1: Table S2). The core-genome, defined as the part of
the genome common to all isolates, contained 3944
genes, representing 93% of the average gene content of
the isolates (Fig. 1a). The dispensable genome (the set of
genes shared by some—but not all—isolates) contained
803 genes, while the unique genome (genes present in
only one isolate) contained 1855 genes (Fig. 1a). The
pan-genome, corresponding to the sum of the core, dis-
pensable and unique genomes was composed of 6602
genes. The curves for the pan and core genomes (Fig.
1b) indicated the number of core genes (green line) sta-
bilized after the addition of the tenth genome. The pan-
genome fitting parameter (γ = 0.67; blue line) indicates
an open pan-genome [30]. Figure 1c shows the propor-
tion of clusters of orthologous group (COG) classes for
the core, dispensable and unique genomes. As the core
genome represented 93% of the average number of genes
in the isolates, it is reasonable that core genes make the
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bulk of COG classes (Fig. 1c). Moreover, as typical for
bacteria, none of the detected genes were related to nu-
clear structure (class Y); genes in COG classes B (Chro-
matin structure and dynamics) and Z (Cytoskeleton)
were not detected either. A number of classes, including
K (Transcription), L (Replication, recombination, and re-
pair), and X (Mobilome: prophages, transposons) were
represented more frequently in the dispensable genome
than the unique and core genomes. We verified the loca-
tion of the genes in classes K, L and X; 49, 39 and 14%
of those genes were within prophage regions. In the
unique genome set, the most common gene classes were
J (Translation, ribosomal structure, and biogenesis), D
(Cell cycle control, cell division, chromosome partition-
ing), V (Defense mechanisms) and M (Cell wall/mem-
brane/envelope biogenesis).
Fig. 1 Pan and core genome analysis. a The pan-genome of the 73 Salmonella Typhi isolates contains 6602 genes. The pan-genome can be
further divided into the unique genome (orange), dispensable genome (red) and core genome (blue), depending on how many isolates share a
given gene. b Core and pan-genome curves. The number of core genes stabilizes after the addition of the tenth genome. The pan-genome is
open according to the fitting parameter γ = 0.67. c Distribution of genes in the unique, dispensable and core genomes on in each COG class.
COG classes are as follows: [J] Translation, ribosomal structure and biogenesis; [A] RNA processing and modification; [K] Transcription; [L]
Replication, recombination and repair; [B] Chromatin structure and dynamics; [D] Cell cycle control, cell division, chromosome partitioning; [Y]
Nuclear structure; [V] Defense mechanisms; [T] Signal transduction mechanisms; [M] Cell wall/membrane/envelope biogenesis; [N] Cell motility; [Z]
Cytoskeleton; [W] Extracellular structures; [U] Intracellular trafficking, secretion, and vesicular transport; [O] Post-translational modification, protein
turnover, chaperones; [X] Mobilome: prophages, transposons; [C] Energy production and conversion; [G] Carbohydrate transport and metabolism;
[E] Amino acid transport and metabolism; [F] Nucleotide transport and metabolism; [H] Coenzyme transport and metabolism; [I] Lipid transport
and metabolism; [P] Inorganic ion transport; [Q] Secondary metabolites biosynthesis, transport and catabolism; [R] General function prediction
only; [S] Function unknown; [−] Unclassified
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Presence of Salmonella genomic island 11 (SGI11)
Twenty-one of the 73 isolates harbored a genomic island
similar to SGI11. Manual curation of gene content re-
vealed that not all of these genomic islands were arche-
typical. Some isolates had the same gene content as
SGI11 (n = 8), and we identified four variants that we
named SGI11b (n = 9), SGI11c (n = 1), SGI11d (n = 1)
and SGI11e (n = 2; Fig. 2).
Usually, SGI11 genomic islands contained antimicro-
bial resistance genes (blaTEM-1, catA1, strA, strB, sul1,
sul2 and dfrA7), mercury resistance genes (merE, merD,
merA, merC, merP, merT and merR; Fig. 2a) and the qac-
EΔ1gene that encodes ethidium-bromide resistance pro-
tein, a member of the small multidrug resistance (SMR)
family [31]. SGI11 was previously found to interrupt the
nlpC or yidA gene (Chiou et al. [15]. All archetypical
SGI11 in our Bangladeshi isolates disrupted the yidA
gene, which encodes a sugar phosphate phosphatase.
One isolate that contained the archetypical SGI11 se-
quence had inversion of the segment containing the strB,
strA and sul2 genes (Fig. 2a, red dotted bridge); this in-
version was also observed in SGI11d (Fig. 2d). Similarly
to archetypical SGI11, SGI11b, c, and d also disrupted
the yidA gene, but contained deletions of 7857 bp (re-
gion encoding blaTEM-1, strA, strB and sul2), 1317 bp
(region encoding catA1), or 9959 bp (region encoding
catA1, sul1, dfrA7 and qacEΔ1), respectively (Fig. 2b-d).
SGI11e was located between the cyaY and cyaA genes,
missing a 5651 bp region (encoding strB, strA and sul2)
and the direction of the AMR genes and IS elements
were reversed (Fig. 2e). None of the SGI11 variants
interrupted the nlpC gene, which has been described
previously by Chiou et al. [15] as one of the probable in-
sertion sites for the island.
Plasmids
Five different types of plasmids were detected and as-
sembled, and ranged in size from 43,427–218,627 bp
(Table 1). In total, 50 of the 73 isolates harbored
plasmids: 49 isolates harbored just one type of plas-
mid and isolate 311189_217186 harbored two plas-
mids, matched (by homology) with NC_003384 and
NC_003385, known as pHCM1 and pHCM2 respect-
ively [32]; see Table 1.
Twenty pHCM1-like plasmids were assembled, and
ranged in size from 214,596–218,627 bp. All pHCM1-
like plasmids harbored similar resistance genes as SGI11
(Fig. 2a). We also assembled 21 pHCM2-like plasmids;
17 were 106,706 bp and four were 106,705 bp, ~ 200 bp
longer than the reference pHCM2 (NC_003385) plasmid
sequence of S. Typhi CT18. However, the gene content
of the short and long pHCM2 plasmids were the same
as the reference [32].
Another plasmid, which we named pK91, was present
in seven isolates. This plasmid ranged in size from 91,
848–93,445 bp, harbored the qnrS1, blaTEM-1, sul2, tetR,
Fig. 2 The genomic island SGI11 and its variants. Red arrows are resistance genes, grey dashed arrows are mercury metabolism genes, black
arrows are insertion elements and transposases. Colored dashed lines denote segments in the archetypical SGI11 (a) that are absent in other
variants. Red dashed bridge denotes an inversion. yidA// (double forward dash means a truncation) and cyaY-cyaA denote the sites of insertion of
the islands. b SGI11b. c SGI11c. d SGI11d. e SGI11e. The ruler gives an approximate island size
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and tetA resistance genes, and shared 66% query cover-
age (at 99% identity in the aligned portions) with a plas-
mid from E. coli (CP026578). Our single ceftriaxone-
resistant isolate contained an 88,544 bp plasmid, previ-
ously described as pPRJEB21992, that harbored blaTEM-1
and blaCTX-M-15 [11]. Both pK91 and pPRJEB21992 con-
tained a compendium of type IV secretion system genes.
Recently, Klemm et al. [10] described a promiscuous
plasmid, p60006, that confers resistance to fluoroquino-
lones and third-generation cephalosporins. This plasmid
harbored the qnrS1, blaTEM-1 and sul2 genes (similarly
to pK91) and the blaCTX-M-15 and blaTEM-1genes (simi-
larly to pPRJEB21992). Figure 3a, b and c shows a com-
parison of the regions carrying resistance genes in
p60006, pK91 and pPRJEB21992, respectively. One iso-
late (ID: 343077_281186) contained a 43,427 bp plasmid,
which we named pK43, with high similarity to the 38
Kbp pSTY1 (CP009103) plasmid from Salmonella
Typhimurium strain ATCC 13311. This plasmid lacks
resistance genes, but encodes genes for pili formation
and conjugation.
SGI11, plasmids and comparison with genotypes and
MLST
Comparison of the SNP-based genotyping data with
the presence of plasmids and SGI11 revealed few re-
markable associations. Except for the three isolates
(3/73) with undetermined genotype data, all isolates
that carried pK91 plasmids (n = 7), pHCM1 plasmids
(n = 20) or any variant of SGI11 (n = 21) were from
genotype 4.3.1 (Haplotype 58, H58; Additional file 2:
Table S3). Moreover, all isolates with SGI11 variants
(19/70) belonged to H58-lineage Ia. No isolates from
Table 1 Plasmids and genomic islands detected in the 73 S. Typhi isolates. The resistance genes present in these elements are listed
Name Size range (bp) or location Number Resistance genes
Plasmids pHCM1 214,596 - 218,627 20 blaTEM-1; catA1; strA; strB; sul1; sul2; dfrA7; qacEΔ1
pHCM2 106,706 - 106,706 21 –
pK43 43,427 1 –
pPRJEB21992 88,544 1 blaTEM-1; blaCTX-M-15
pK91 91,848 - 93,445 7 blaTEM-1; sul2; qnrS1; tetA; tetR
Genomic Islands SGI11 yidA 8 blaTEM-1; catA1; strA; strB; sul1; sul2; dfrA7; qacEΔ1
SGI11b yidA 9 catA1; sul1; dfrA7; qacEΔ1
SGI11c yidA 1 blaTEM-1; strA; strB; sul1; sul2; dfrA7; qacEΔ1
SGI11d yidA 1 blaTEM-1; strA; strB; sul2
SGI11e cyaY-cyaA 2 blaTEM-1; catA1; sul1; dfrA7; qacEΔ1
Fig. 3 Comparison of the resistance-gene containing regions of the plasmids a p60006, b pK91 and c pPRJEB21992. The dashed blue box indicates
the qnrS gene common to p60006 and pK91. The dashed blue line indicates the blaCTX-M-15 gene common to p60006 and pPRJEB21992. The red
dashed line indicates blaTEM-1 is common to all three plasmids
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other H58 lineages or other genotypes contained
SGI11 (Fig. 4, Additional file 2: Table S3).
In contrast, only one lineage Ia isolate had the pHCM1
plasmid. All other isolates with this plasmid (18/70)
belonged to the newly described H58-lineage Bd; only
one strain from this lineage did not contain the pHCM1
plasmid. However, none of these isolates were from the
Bd sublineage Bdq. In contrast, all isolates from the Bdq
sublineage (n = 7) carried a pK91 plasmid (Fig. 4, Add-
itional file 2: Table S3).
All isolates carrying pHCM2 had either genotype 3.3
(n = 4) or 4.3.1 (n = 14). All isolates with the 4.3.1 genotype
were from lineage Ia (n = 14). Only genotype 3.2.2 isolates
carried the pK43 plasmid (Additional file 2: Table S3).
ST1 was the dominant MLST type among our isolates
(n = 52), followed by ST2 (n = 18) and ST2209 (n = 3).
Forty-six of the 52 ST1 isolates had either a resistance
plasmid (pHCM1 or pK91) or a variant of SGI11. In
contrast, only one of the 18 ST2 isolates carried
pHCM1; no ST2 isolates carried pK91 and only one ST2
isolate had SGI11. None of the ST2209-type isolates had
either a plasmid or SGI11.
The ceftriaxone-resistant isolate with the pPRJEB21992
plasmid had the 3.3 genotype and ST2 type.
Resistance profiles
Our 73 isolates were classified into 12 resistance profiles
(Table 2), of which two were multidrug resistant (MDR)
Fig. 4 Comparison of 73 isolates from Bangladesh in a MLST-derived UPGMA tree. The tree is colored by MLST type. Different data points,
including genotype, H58-lineage details, presence of different variants of SGI11, resistant_plasmids and unresistant_plasmid (which are not
involved with AMR) are indicated in different circles around the tree (by colors)
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and 10 were non-MDR (nMDR). Thirty-six of the 37 iso-
lates with ampicillin resistance contained plasmids and/
or SGI11 variants, namely pHCM1 (n = 20 isolates),
pK91 (n = 6), pPRJEB21992 (n = 1), SGI11 (n = 6),
SGI11c (n = 1), SGI11d (n = 1) and SGI11e (n = 2; Table 3,
Additional file 2: Table S3). Two isolates with SGI11 and
one with pK91 were susceptible to ampicillin, despite
carrying blaTEM-1. Isolates with SGI11b, pK43, and
pHCM2 were blaTEM-1-free and susceptible to
ampicillin, with one exception: one isolate harboring
SGI11b without blaTEM-1 was ampicillin-resistant.
Only one of the 73 isolates was resistant to ceftriaxone
(Table 3, Additional file 2: Table S3). This isolate was
also resistant to ampicillin, and harbors the
pPRJEB21992 plasmid that encodes both blaTEM-1 and
blaCTX-M-15. In terms of ciprofloxacin resistance, we
identified multiple mutations in the gyrA and parC
genes, including S83F, S83Y, D87G, and D87N in gyrA;
Table 2 Resistance profiles of the S. Typhi isolates. (R) resistant; (S) susceptible; amp, ampicillin; sxt, cotrimoxazole; chl,
chloramphenicol; cip, ciprofloxacin; cro, ceftriaxone
Number of Isolates Resistance Profile Plasmids/Genomic Islands present
26 amp-R, sxt-R, chl-R, cip-R, cro-S pHCM1 (20); SGI11 (5)
15 amp-S, sxt-S, chl-S, cip-R, cro-S SGI11(1); pK91 (1)
10 amp-S, sxt-S, chl-S, cip-S, cro-S –
7 amp-R, sxt-S, chl-S, cip-R, cro-S SGI11d (1); pK91 (6)
6 amp-S, sxt-R, chl-R, cip-R, cro-S SGI11 (1); SGI11b (5)
2 amp-S, sxt-S, chl-R, cip-R, cro-S SGI11b (2)
1 amp-R, sxt-R, chl-R, cip-S, cro-S SGI11 (1)
1 amp-R, sxt-R, chl-S, cip-R, cro-S SGI11c (1)
2 amp-R, sxt-S, chl-R, cip-R, cro-S SGI11e (2)
1 amp-R, sxt-S, chl-S, cip-S, cro-R pPRJEB21992 (1)
1 amp-S, sxt-R, chl-R, cip-S, cro-S SGI11b (1)
1 amp-S, sxt-S, chl-R, cip-S, cro-S SGI11b (1)
Table 3 Summary of resistance to each antibiotic tested. The genes associated with a given resistance profile, as well as the
number of susceptible (S) or resistant (R) isolates, are shown. For ciprofloxacin resistance, we also show mutations on gyrA/B and
parC/E genes
# resistant isolates # susceptible isolates Associated resistance gene
(number of genes)
gene:mutation:number of
isolates with mutations
Ampicillin 38 35 bla-tem-1 (40) Not applicable
Ceftriaxone 1 72 bla-ctx-m-15 (1) Not applicable
Ciprofloxacin 59 14 qnrS1 (7) gyrA:S83Y:29
gyrA:S83F:28
gyrA:D87G:2
gyrA:D87N:3
gyrA:N529S:6
gyrA:D538N:52
gyrB:S464F:9
parC:S80I:1
parC:S80E:1
parC:E84K:2
parE:S339 L:1
parE:A364V:7
parE:L416F:1
Chloramphenicol 39 34 catA1 (39) Not applicable
Cotrimoxazole 35 38 sul1 (39); sul2 (36); dfrA7 (40) Not applicable
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S80I, S80R, and E84K in parC (Table 3). A quinolone re-
sistance (qnr) gene, qnrS1 was detected in seven isolates
and carried by a plasmid (herein called pK91) which also
had a blaTEM-1 gene [33] (Table 3). Both gyrA and parC
mutations, and the qnr genes were associated with re-
sistance to ciprofloxacin (Additional file 2: Table S3).
Other detected mutations in the non-QRDR regions in-
clude N529S, D538N of gyrA, S464F of gyrB, and S339 L,
A364V and L416F of parE (Table 3).
The catA1 gene was present in pHCM1, SGI11 and the
SGI11b and e variants. Only one isolate with catA1
showed susceptibility to chloramphenicol. Another isolate
was phenotypically resistant to chloramphenicol, but did
not contain a plasmid or SGI11 carrying the catA1 gene.
Thirty-five isolates were resistant to cotrimoxazole. Of
these, 27 had the three aforementioned dfrA1, sul1, and
sul2 genes, six had the dfrA1 and sul1 genes, and one
isolate only had the dfrA1 gene (Table 3, Additional file
2: Table S3). One cotrimoxazole-resistant isolate did not
harbor dfrA1, sul1 or sul2 genes. Thirty-eight isolates
were classified as being susceptible to cotrimoxazole, 24
of these isolates did not have any of the dfrA1, sul1 or
sul2 genes. Eight cotrimoxazole-susceptible isolates had
a sul2 gene, five had only dfrA1 and sul1 genes, and one
isolate had all three genes.
Discussion
In agreement with previous findings [34], all 73 S. Typhi
genomes in this study were highly conserved, as con-
firmed by the ANI values (> 98%; Additional file 1: Table
S2) and whole genome alignments (Additional file 3: Fig-
ure S1). However, the presence or absence of SGI11-like
elements led to sequence differences and variation in
genome size.
The core genome analysis also indicated high genomic
conservation between our 73 isolates, with 3944 genes in
the S. Typhi core genome (60% of the pan-genome). In
contrast, a previous study of only six isolates identified
4131 core genome genes [35]. The limited geographical
origin (Bangladesh) of our isolates could explain the low
number of genes in the core genome. Conversely, the
higher number of isolates in this study (73 vs. 6 in Bad-
dam et al., 2015) may explain the differences in the pan-
genome content (6602 vs. 5426 genes). In contrast, the
Salmonella enterica pan-genome has a higher gene
number but smaller core genome than the S. Typhi iso-
lates in this study. This difference is to be expected, as
the Salmonella enterica dataset included multiple sero-
vars [36]. Interestingly, our S. Typhi pan-genome con-
tains a higher number of genes than S. Paratyphi-A
(4670; 41 isolates) and S. Enteritidis (4750; 159 isolates),
but a smaller number of genes than S. Typhimurium
(7603; 47 isolates; [37]. These findings corroborate the
hypothesis that the pan-genome size does not reflect the
host range or ability to colonize multiple hosts [37, 38].
However, the accessory genome or serovar-specific
core genome could be responsible for such host variety
(Seif et al., 2018). Considering the host restriction of S.
Typhi, the same rationale could explain why 93% of the
average gene content of our isolates was present in the
core genome. In contrast, serovars like S. Typhimurium
with a variable host range have 75% of its average gene
content in its core genome (3475/ 4661) [37]. Variation
within a serovar should be reflected in the dispensable
genome, whereas the unique genome should explain
strain-specific characteristics. Our S. Typhi dispensable
genome showed enrichment of COG classes X (n = 48),
L (n = 38), K (n = 33), S (n = 23; function unknown), C
(n = 22) and E (n = 21). Class X refers to genes related to
prophages and transposons; we found ~ 50% of class X
genes in the dispensable genome were located in the
prophage regions of the S. Typhi genome. Moreover, ~
40% of class L (DNA repair) genes in the dispensable
genome were located in prophage regions. Prophage-like
elements in Salmonella serovars can play a role in re-
combination, contribute to virulence in the host and
carry specific virulence-associated genes such as sopE. In
the case of S. Typhi, these regions could even cause
more subtle intra-serovar variation (Boyd and Brüssow
2002; Thomson et al. 2004). These prophage regions
have also been reported to contribute to mechanisms of
DNA repair, possibly as a part of the bacterial SOS regu-
latory system (Balbontín et al. 2006). Our core S. Typhi
genome lacked a number of COG classes, including Y
(genes related to nuclear structure), B (Chromatin struc-
ture and dynamics) and Z (Cytoskeleton). This result
could be an artifact of COG class annotation, as the
current version of the COG database does not include in
their classes bacterial genes related to chromatin-like
organization or cytoskeletal formation, even though
there are only but a few genes on those related functions
for bacteria. Also there may be a lack of annotation of
genes related to those classes.
Remarkably, our analysis of 73 S. Typhi genomes sug-
gested an open pan-genome, in contrast to previous
studies that reported Salmonella enterica had a closed
pan-genome [36, 39]. However, these previous studies
were mainly performed on the Salmonella genus, not
specifically the Typhi serovar. Moreover, the low num-
bers of S. Typhi isolates in these studies could lead to
discrepancies in the pan-genome results [36, 39]. An
open pan-genome usually indicates bacterial species that
can colonize multiple environments and exchange gen-
etic material in multiple ways. Other more conserved
species that tend to live in isolated niches with limited
access to the microbial gene pool or that have a lower
capacity to acquire foreign genes usually show a closed
Lima et al. BMC Genomics          (2019) 20:530 Page 8 of 15
pan-genome [40]. Considering its human host-
restriction, S. Typhi should have a closed pan-genome.
However, typhoid fever is endemic in many highly-
populated areas of the world, where the bacteria are
transmitted through contaminated food and water. Such
transmission mediums contains vast bacterial commu-
nity, acting as a bacterial gene pool, which may reflect in
an open pangenome [36, 39]. Moreover, prophage regions
of the genome may work as hotspots for the acquisition of
new genes in those regions [41]. The core/pan-genome ra-
tio, 0.6 (3944/ 6602) in our study also points to open pan-
genome, as discussed previously by Rouli et al. 2015 [41].
In Addition, the number of pseudogenes in our S. Typhi
isolates was higher; median 177 (4%), similar to ~ 200 in
S. Typhi CT18 reference genome, compared to S. Typhi-
murium (0.9%) or, Escherichia coli K12 (0.7%). A high
number of pseudogenes in bacterial species could be asso-
ciated with its host restriction, as it has been observed in
other bacteria [34]. Certain genes required for a broad
range of hosts may become pseudogenes, once bacteria
get adapted to only one preferred host [34]. Host-
specificity of S. Typhi is mostly due to the strong selectiv-
ity of typhoid toxin for Neu5Ac- terminated glycans over
Neu5Gc-terminated ones and the absence of an oper-
ational Rab32-dependent host defense pathway in human.
Neu5Ac- terminated glycans are predominantly expressed
in human cells, while the Neu5Gc- terminated ones are
dominant in other mammals [42–44]. It could be the
reason why gtgE (a cysteine protease) and sopD2 (Type III
secretion system effector protein) genes became pseudo-
genes or missing in S. Typhi genome, as reported earlier
[32, 42]. Both the genes are present in other Salmonella
(e.g. Typhimurium) to protect the bacteria from Rab32-
dependent host defense pathway in other mammalian
hosts (e.g. Chimpanzees) [32, 42].
Despite high sequence conservation, we observed
some differences in the resistance gene contents of our
isolates, and these differences were reflected in the
phenotypic resistance profiles (Table 2). This variation in
resistance can be attributed to the mutations occurring
on antibiotic target genes and the presence of acquired
resistance genes carried on plasmids or SGI11-like
islands. Different variants of SGI11, with different gene
contents or orientations and locations in the chromo-
some, were observed among our isolates. Four of the five
SGI11 variants interrupted the yidA gene of the S. Typhi
genome, while SGI11e was located between the cyaY
and cyaA genes (Table 1); both locations have previously
been described [15, 16, 18].
The presence of the archetypal SGI11 sequence,
SGI11b, d or e, or pHCM1 conferred chloramphenicol
resistance, as these elements harbor the catA1 gene; the
catA1 gene was missing from SGI11c. Only two isolates
did not exhibit the corresponding resistance or
susceptibility phenotypes based on the presence or ab-
sence of catA1. However, even if the catA1 gene is ab-
sent, other mechanisms such target gene mutations or
the presence of an efflux pump can confer resistance
[45]. In contrast, a decrease in the concentration of
acetyl-CoA can inhibit the activity of catA1 and lead to
a susceptibility phenotype, even in the presence of the
catA1 gene [46].
Among the isolates exhibiting an ampicillin-resistant
phenotype, the blaTEM-1 beta-lactamase gene was
present in all SGI11 variants (except variant b) and
the pHCM1, pK91 and pPRJEB21992 plasmids (Figs.
2 and 3). However, three isolates were susceptible to
ampicillin despite harboring the blaTEM-1 resistance
gene; this could be related to altered transcriptional
control due to a weak bla gene promoter [47]. How-
ever, analyses of the promoter regions did not reveal
any variation (data not shown). Ampicillin resistance
in the absence of a blaTEM-1 gene was also observed
for one isolate, which may indicate the involvement
of other resistance mechanisms like overexpression of
efflux pump genes [48–50].
Unlike ampicillin and chloramphenicol, cotrimoxazole
is a drug combination of trimethoprim and sulfameth-
oxazole, which exert a synergistic bacteriostatic effect.
One mechanism of cotrimoxazole resistance involves the
acquisition of folate-biosynthesis pathway genes that are
resistant to the bacteriostatic effect [51, 52]. These re-
sistance genes can be carried by plasmids or integrons,
and the combined presence of a resistant dihydroptero-
ate synthase gene (sul1 or 2) and dihydrofolate reductase
(dfr) can confer resistance to cotrimoxazole. Indeed,
most of our resistant isolates contained the dfrA7, sul1
and sul2 genes. Other isolates had either dfrA7 and sul1,
or only dfrA7. The sul2 gene does not confer a resist-
ance phenotype on its own. In contrast, six of our
cotrimoxazole-susceptible isolates had a dfrA7 gene with
a sul1 and/or sul2 gene. However, similar discrepancies
were also reported from other studies who compared
whole genome sequence (WGS) with antimicrobial sus-
ceptibility data [53–56].
Only one of the 73 isolates exhibited a resistance
phenotype to ceftriaxone, which could be explained
by the presence of a blaCTX-M-15 gene on a
pPRJEB21992 plasmid. A highly ceftriaxone-resistant
S. Typhi was previously reported in Bangladesh in
1999 [57], but this isolate was not subjected to mo-
lecular characterization. Djeghout et al. [11] described
the first assembled plasmid harboring blaCTX-M-15,
pPRJEB21992, from a Bangladeshi strain isolated in
2000. We studied the same strain to compare it with
other resistance plasmids we found in this study. An-
other plasmid, p60006, which harbors the same gene
for ceftriaxone resistance was reported in a S. Typhi
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strain that caused an outbreak in Pakistan during
2016 and 2017 [10]. Both plasmids, pPRJEB21992 and
p60006, may be the same type, but have different
gene contents. Moreover, these plasmids possibly have
different evolutionary origins or took different pat-
terns of divergence, as whole-genome SNP (wgSNP)
analyses revealed genotypic and phylogenetic differ-
ences between the isolates, including differences in
the blaCTX-M-15 gene sequence (99% identity and 92%
coverage); [58]. Considering the origin of both of
these plasmids as independent events, the chance of
strains carrying any of these plasmids spreading is
low, but cannot be ruled-out as both plasmids are
extra-chromosomal elements. A significant increase of
AMR may occur if strains carrying either of these
two plasmids spread outside of their current geo-
graphical origin.
Unlike other antimicrobial agents, resistance to cipro-
floxacin (cip) was common among our isolates and was
associated with mutations in the gyrA/B and parC/E
genes, which encode the DNA gyrase and topoisomerase
IV enzymes, respectively. Indeed, 55 of the 59 cip-
resistant isolates contained the S83F and S83Y mutations
in the gyrA gene. Another gyrA mutation, D538N was
also common (52/73 isolates), but is not located in the
QRDR region of the gene and should not influence sus-
ceptibility to cip [59]. Moreover, this gyrA-D538N muta-
tion and two other mutations, gyrA-N529S and parE-
A364V were associated with the different genotypes of
the S. Typhi isolates but were not involved in cip resist-
ance [58]. Resistance can also be conferred by the qnr
genes [60]. Remarkably, the seven isolates with pK91
plasmids containing the qnrS1 gene had high cip MICs
(> 4.0 μg/mL, Additional file 2: Table S3). These isolates
also contained the gyrA-S83Y mutation, but did not have
other mutations in the gyrB, parC or parE genes. The
wgSNP analysis identified these isolates are part of a
highly cip-resistant local H58-sublineage, Bdq [58]. S.
Typhi isolates from a Pakistani outbreak also contained
qnr genes in the p60006 plasmid and were highly resist-
ant to ciprofloxacin [10].
The gene contents of the p60006, pK91 and
pPRJEB21992 plasmids were noticeably different (Fig. 3).
However, the presence of a type IV secretion system and
common IS elements in these plasmids suggest a common
ancestor, and then independent patterns of divergence.
The pHCM2 and pK43 plasmids had no association with
resistance or other metadata (Additional file 4: Table S1
and Additional file 2: Table S3).
Surprisingly, the presence of the pHCM1 and pK91
plasmids and SGI11 islands were associated with the S.
Typhi genotype and H58 lineage. With the exception of
pPRJEB21992, all AMR-related plasmids and SGI11 were
detected in isolates with genotype 4.3.1 (Haplotype 58,
H58). The seven isolates with high cip MICs that har-
bored the pK91 plasmid were from the newly reported
H58 sublineage, Bdq (Tanmoy et al., 2018). The isolates
carrying pHCM1 plasmids, which confer MDR and cip
resistance, were from the local Bd lineage (but not the
Bdq sublineage), while isolates with SGI11 were from
lineage Ia (Additional file 2: Table S3). Thus, the local S.
Typhi lineage, Bd, appears to be less prone to chromo-
somal integration of the MDR locus than the globally
widespread lineage Ia. The presence of pHCM1 and/or
pK91 plasmids in lineage Bd isolates could also suggest
the unaltered fitness of the lineage. Cip resistance con-
ferred by gyrA/B and parC/E mutations did not provide
any fitness advantage either, as they cannot offer any as
previously reported [61]. However, the presence of gyrA/
B and parC/E mutations in 72 of our 73 isolates could
indicate strong selective pressure on the genome from
the overuse of antimicrobials [34].
The effect of such anthropological selective pressure
could be particularly evident in Bangladesh and other
South Asian countries. Self-medication and over-the-
counter sale of antibiotics, especially ciprofloxacin, is
prevalent in this region; ciprofloxacin has been one of
the preferred treatments for enteric or diarrheal dis-
eases since the 2000s [62, 63]. The high concentra-
tions of this drug in meat products (chicken and
livestock) can also contribute to cip resistance in the
environment, leading to increased selective pressure
[64, 65]. This strong selective pressure could have
played a crucial role to limit the spread of lineage Bd
to specific geographic regions. In contrast, lineage Ia
may represent the major evolutionary event of inte-
gration of the MDR locus into the chromosome to
maintain the MDR phenotype, as well as a gain of fit-
ness advantages [16].
Besides revealing these characteristics of S. Typhi, we
obtained the complete chromosome sequences for 73 iso-
lates, which substantially increases the number of
complete (closed) chromosome sequences for this serovar
available in the NCBI (only 46 sequences were available
until now). However, the isolates in this study were only
collected from pediatric patients as the disease is most
common among school-aged children, but typhoid can
occur at any age. Thus, only studying isolates from
pediatric cases may not provide a complete picture of S.
Typhi in Bangladesh. Moreover, the number of isolates in
our study (n = 73) may be too low to detect all genetic
changes that have occurred over the 15 years between
1999 and 2013, specifically chromosomal integration of
the MDR locus. All of our isolates were from Bangladesh,
which makes our pan-genome data relatively country-
specific. However, as a tropical country where typhoid is
endemic, our core and pan-genome data should reflect
the scenario of a region where S. Typhi is endemic.
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Conclusions
We assembled and annotated complete chromosome
and plasmid sequences for 73 S. Typhi isolates using
only short-length Illumina reads. The isolates exhibited a
highly conserved genome, with an open pan-genome.
We report two new plasmids, pK43 with no link to re-
sistance and pK91 that confers a high level of ciprofloxa-
cin resistance. Multiple variants of SGI11 with different
resistance genes were detected, and result in different re-
sistance phenotypes. Plasmids carrying resistance genes
were also present in many isolates with different pheno-
types. The presence of SGI11 and plasmids encoding re-
sistance genes (pHCM1 and pK91) were associated with
two different H58 lineages, Ia and Bd, respectively. Shed-
ding the plasmids and integration of the resistance genes
into the genome (as islands) may have contributed to
the fitness of the lineage Ia isolates; this could be one ex-
planation for the wider geographical spread of this
lineage, in comparison to the local lineage Bd that has
remained restricted to Bangladesh. The results of this
study should help us to better understand the multiple
variations in the genomic elements that confer AMR in
S. Typhi. Continuous surveillance of these elements
could reveal other mechanisms by which AMR can
spread in S. Typhi. However, preventive measures to
minimize the spread of AMR should also be imple-
mented, for example vaccination could be an effective
tool to reduce the number of cases by preventing the
overuse of antibiotics [66].
Methods
Bacterial strains and resistance profiles
All Salmonella Typhi isolates used in this study were
collected by the Child Health Research Foundation
(CHRF) from the blood of pediatric patients hospitalized
at Dhaka Shishu (Children) Hospital (DSH) or pediatric
outpatients treated at the Popular Diagnostic Centre
(PDC) in Dhaka, Bangladesh. The CHRF team has been
preserving Salmonella isolates since 1999 and currently
maintains a biobank of over 3500 isolates.
Seventy three S. Typhi isolates were selected from the
biobank based on their antimicrobial resistance pheno-
type (Table 2). We re-confirmed the identity of all
strains using standard biochemical tests and agglutin-
ation tests with specific antisera for Salmonella species
(Thermo Scientific, Waltham, MA, USA). Antimicrobial
susceptibility to ampicillin (amp), cotrimoxazole (sxt)
and chloramphenicol (chl) were determined using disk
diffusion assays (Oxoid; Thermo Scientific). Broth-
microdilution was employed to determine the minimum
inhibitory concentrations (MIC) for ciprofloxacin (cip)
and ceftriaxone (cro) (Sigma Aldrich, St. Louis, MO,
USA). All zone diameters and MIC data were inter-
preted according to EUCAST v8, 2018 ([67], 2018).
Metadata for all 73 isolates (sample, organism, year of
isolation, setting, patient age [months] and sex) are pre-
sented in Additional file 4: Table S1.
DNA sequencing, genome assembly, genome annotation
and comparative genomics
Isolates were cultured on MacConkey agar (Oxoid,
Thermo Scientific) overnight, checked for visible con-
tamination (and re-plated if any contamination was ob-
served), and all colonies were picked and suspended in
water. QIAamp DNA Mini Kits (Qiagen, Hilden,
Germany) were used to extract DNA from the suspen-
sions on the same day. Whole genome sequencing
(WGS) was performed using an Illumina-HiSeq 4000
platform, generating 2 × 150 bp paired-end reads with an
average coverage of 121x, at The Oxford Genomics
Centre of the Wellcome Trust Centre for Human Genet-
ics, Oxford, UK.
Quality assessment of sequencing reads was conducted
using FastQC [68]. Due to the high-quality scores of the
reads and absence of adapter sequences, quality and read
trimming were deemed unnecessary. Paired-end reads
were first assembled using Newbler v3.0 [69]. More than
99.37% of assembled bases for all isolates had Q40 or
more, as calculated using Newbler. We used JSpecies
[70] to calculate the average nucleotide identity (ANI)
with BLAST ([ANIb]; [71] and Mummer ([ANIm]; [72]
for all isolates plus Salmonella enterica subsp. enterica
serovar Typhi str. CT18 (accession NC_003198.1).
ANIb/ANIm of our isolates in comparison to S. Typhi
CT18 were higher than 99,85% which allowed scaffolds
to be aligned against S. Typhi CT18 using cross_match
[73] to create a layout of ordered and oriented scaffolds
to be concatenated with gaps between scaffolds esti-
mated from the alignment and filled with ‘N’. The layout
of scaffolds was subjected to manual curation in order to
1) verify any missing scaffolds on the alignment; 2) con-
firm gap sizes; and 3) confirm the expected number of
repeated scaffolds in agreement with their read coverage
estimated by Newbler. This curated superscaffold was
subjected to gap filling in two steps. In the first step, we
used GapFiller v1.11 [74]. In step 2, remaining intra-
and inter-scaffold gaps that were not closed by GapFiller
v1.11 were locally assembled using Newbler v3.0. Reads
present at both ends of a gap were selected and assem-
bled. Contigs obtained this way and that spanned the
gap and anchored on consensus sequences on both sides
were added to the consensus, thus filling the gap. Step 2
was done manually to each remaining gap from step 1
and subjected to confirmation of each closed gap to
avoid erroneous gap filling. Scaffolds that did not align
to the chromosome of S. Typhi CT18 were aligned to
the nt NCBI database in order to verify if they had plas-
mid origin. Those with plasmid origin were assembled
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using the approach described previously. Visual aid to
the assembly process can be found in the Additional file
5: Figure S2. A similar approach was previously used to
close a Klebsiella genomes [75]. The SABIA pipeline was
used for automated annotation [76]. Assembled se-
quences were submitted to the NCBI (accession IDs are
shown in Additional file 4: Table S1).
During the superscaffold formation step, the presence of
a Salmonella genomic island (SGI) was noticed in 21
strains, due to careful manual curation of the superscaffold
formation step. This island carries several resistance genes
and is not present in the reference S. Typhi genome. Based
on sequence similarity and gene content, the SGI was iden-
tified as Salmonella genomic island 11 ([SGI11] accession
number KM023773; [15]. According to Chiou et al. [15],
SGI11 can be located at two chromosomal positions, inter-
rupting the yidA gene or nlpC gene. Contigs were aligned
against the SGI11, nlpC and yidA sequences to determine
the presence of the island and its position of insertion. For
strains in which there was evidence of a SGI11 element but
neither yidA nor nlpC were interrupted, the extremities of
the contigs harboring the segments of the island were lo-
cally assembled and the gene neighborhood was deter-
mined after annotation.
To observe conserved synteny blocks, we aligned all
isolates and S. Typhi CT18 using Progressive Mauve
[77]. We used RPS-BLAST, a variant of PSI-BLAST [78]
to identify proteins with homology to COG protein pro-
files in the NCBI database at an e-value of 0.001. The
best hit was selected and COG cluster classification was
transferred to the protein query. Pan and core genome
analysis was performed using PGAP v1.2.1 [79]. Coding
sequences, protein sequences and COG classification for
all isolates were used as input, along with an e-value of
1e-10 at 70% identity and similarity. All protein se-
quences were aligned against each other using blastall
and the resulting output was imported into MCL [80], a
part of PGAP, to cluster the genes. After clustering,
PGAP computes the pan and core genomes by strain
combination from 1 to n strains, where n denotes the
maximum number of strains (n = 73 in this study).
Heap’s law and an exponential law were employed to fit
the pan and core genomes, respectively [79]. PanGP was
used to plot the pan and core genome curves [81].
After assembly and annotation of the chromosomes
and plasmids, AMR genes on the SGI11 and plasmids
were manually annotated. We also used Abricate [82] to
corroborate the AMR genes using the following data-
bases: Resfinder, ARG-ANNOT, CARD, NCBI Bacterial
Antimicrobial Resistance Reference Gene Database,
EcOH, PlasmidFinder, VFDB and Ecoli_VF. We verified
prophage regions on the chromosome and plasmids with
PHASTER [83] to verify the presence of some classes of
dispensable genome genes on these elements.
We previously obtained genotype data for 70 of the 73
isolates in this study [58]. The multilocus sequence typ-
ing (MLST) data for the isolates was determined using
Enterobase [84]. The MLST data was used to build a
UPGMA phylogenetic tree. The Euclidean distance
matrix and UPGMA tree were computed using the dist
and hclust functions, respectively, of the R stats package.
The tree was displayed and annotated using the online
version of iTOL v4 [85].
Additional files
Additional file 1: Table S2. Sheet 1. General information about the
isolates assembled. Sheet 2. Average Nucleotide Identity calculated by
BLAST. Sheet 3. Average Nucleotide Identity calculated by MUMMER.
(XLSX 71 kb)
Additional file 2: Table S3. Ampicilin, ciprofloxacin, chloramphenicol,
ceftriaxone, and cotrimoxazole resistance. (XLSX 50 kb)
Additional file 3: Figure S1. Isolate chromosomes were aligned with
ProgressiveMauve. Conserved sequence block can be observed as they
are marked with the same color. (JPEG 4269 kb)
Additional file 4: Table S1. Sheet NCBI ID: Accession numbers for
sequences deposited on NCBI. Sheet Metadata: metadata for the isolates
studied. (XLSX 15 kb)
Additional file 5: Figure S2. Schematic summary of the assembly and
gap filling process. (JPG 256 kb)
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